Moleculin Biotech Inc (NAS:MBRX)
$ 1.77 -0.05 (-2.75%) Market Cap: 5.65 Mil Enterprise Value: -3.21 Mil PE Ratio: 0 PB Ratio: 0.71 GF Score: 36/100

Moleculin Biotech Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) Transcript

Sep 20, 2021 / 08:35PM GMT
Susan Chor
Oppenheimer & Co. Inc. - Analyst

This is Susan Chor from Oppenheimer. I will be covering for Kevin DeGeeter. I want to thank everyone for joining us this afternoon. We have Wally, CEO of Moleculin, to present and take questions. Just as a reminder, please submit questions in the text box. And without further ado, Wally, please begin.

Wally Klemp
Moleculin Biotech, Inc. - Founder, President, CEO & Chairman

Thanks, Susan. And hello, everyone. Again I am Wally Klemp, Co-Founder, Chairman and CEO of Moleculin Biotech, Inc. We do appreciate the opportunity to present at this conference. And we hope you find this information to be helpful.

Moleculin is a NASDAQ-listed company trading under the ticker symbol MBRX, and as such, we do need to make some important disclaimers about the presentation. You can review these disclaimers along with the rest of this presentation at your convenience by visiting the Investors section of our website at moleculin.com.

We built this Company around three core technologies that all originated at

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot